Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Therapeutics for Biodefense and Emerging Infectious Diseases
Henkel, Timothy
Venatorx Pharmaceuticals, Inc., Malvern, PA, United States
Search 5 grants from Timothy Henkel
Search grants from Venatorx Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The fetal-umbilical connection: role of hypoblast/visceral endoderm
Fluorescent Activated Cell Sorter for Unthsc: Molecular Biology
Monitoring Cellular Response to External Stimuli
Testing a Causal Model of Community-Level Alcohol Use, Problems, and Prevention
qHUB - Cyberinfrastructure for Community-Driven Research and Learning in Heat Transfer
Recently added grants:
The role of AXL-ABL axis in Barrett's carcinogenesis
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC
Core A: Administrative Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201600029C-2-0-1
Application #
9566068
Study Section
Project Start
2016-09-23
Project End
2020-01-12
Budget Start
Budget End
Support Year
Fiscal Year
2017
Total Cost
Indirect Cost
Institution
Name
Venatorx Pharmaceuticals, Inc.
Department
Type
DUNS #
962754037
City
Malvern
State
PA
Country
United States
Zip Code
19355
Related projects
Comments
Be the first to comment on Timothy Henkel's grant